I have a copy of that full article (Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw) right here before me. Actually the research concerns oral biphosphonate, not IV (Zometa).
I wanted to go online to JADA to download the entire article and post it, but was unable to.
Basically the abstract says that oral biphosphantes were considered extremely low risk for ONJ in the past, but according to the abstract, there may be more of a risk then what was assumed.
Vicki, if you would like a copy of this entire article, you can either go to:
http://jada.ada.org, then to the Jan 2009 issue.
Or...you can PM my with your address or FAX number and I would be happy to send you a copy of the article.
Also, on the bottom of the article, it gives contact info for Dr. Sedghizadenh. (ofc address as well as email)
Maryanne